Creatine Benefits Depend on Dose, Tissue, and Brain Stress

Darren Candow’s central claim is not simply that creatine “works.” It is that the dose depends on the tissue and the stress state. The familiar three-to-five-gram daily dose is, in his account, mostly a muscle dose. Bone appears to require more. Brain effects are more conditional still: a healthy brain may not need supplemental creatine at all, while a sleep-deprived or otherwise metabolically stressed brain may require substantially higher acute dosing.

Creatine is a natural metabolite synthesized in the liver and brain. The body makes roughly one to three grams per day, while about 95% of total creatine is stored in skeletal muscle. The muscle does not make it; creatine made in the liver is transported through the blood to muscle, and creatine made in the brain tends to stay there.

The physiological explanation is energy. ATP, adenosine triphosphate, is the body’s cellular energy currency. During high-intensity work such as sprinting, weightlifting, or repeated bursts of sport, ATP stores become threatened. Creatine, stored as phosphocreatine, helps regenerate ATP by donating a phosphate group. Candow used the analogy that if ATP is Batman, creatine is Robin: less celebrated, but the rescuer that helps maintain energy availability.

That mechanism explains why creatine first became associated with strength, power, and anaerobic sports. But the same energy logic may matter in other tissues and conditions: bone cells that need to build and maintain structure, neurons under metabolic strain, older adults trying to preserve function, and people whose diet supplies little or no creatine.

The dosing framework he laid out was deliberately practical. For skeletal muscle, five grams daily is a viable dose across the lifespan, with a possible increase to seven or eight grams for people over 50 because creatine in the lower legs may be more jeopardized with age. For bone, the lowest dose he said has shown benefit is about eight grams, with studies using up to 12 grams per day. For a healthy brain, he was more cautious: because the brain makes creatine, it may not need supplementation under normal conditions. But under stress — sleep deprivation, jet lag, night shifts, exams, emergency medicine, military aviation, high-pressure performance — the dose likely rises.

The source used a tabletop “Dosing Dilemma” to separate creatine use into muscle, bone, brain, sleep-deprived, and stressed states, with the scoops increasing as Candow moved from muscle to bone to acute cognitive stress.

Candow personally takes at least 10 grams per day, partly as a “safety net” to cover muscle, bone, and some stress-related demands. After flying across time zones, he said he was taking 20 to 25 grams acutely, then planned to return to 10 grams when back in a less stressed routine. He did not present that acute high-dose use as a general daily recommendation. At those higher levels, he said, researchers do not yet know whether neurons could swell with water, whether long-term mega-dosing could have detrimental effects, or whether natural synthesis could down-regulate.

His phrase for the brain distinction was simple: “A healthy brain likely doesn't need any creatine, but a stressed brain likely does. And the more stressed it is, the higher the dose seems to come into play.”

The most evidence-based general-use dose, as Candow presented it, remains lower. Three grams daily can saturate skeletal muscle in about a month. Five grams daily is a common and effective dose for muscle. Loading — roughly 20 grams per day for five to seven days — saturates muscle faster, but does not change the eventual benefit compared with consistent lower dosing. The tradeoff is tolerability: large doses can cause gastrointestinal irritation and acute water retention.

His emerging preference is “microdosing” across the day. Smaller amounts distributed through the day appear more tolerable, especially for people prone to dizziness, jitteriness, GI discomfort, or fluctuations in water retention. Candow puts five grams in a water bottle during workouts, consumes some in the morning, and spreads intake rather than taking everything at once.

Darren Candow identified five recurring myths that keep people from taking creatine: kidney damage, water retention, the idea that it is only for men, hair loss, and muscle cramps. His rebuttals were not all the same type. Some were safety arguments. Some were mechanistic corrections. Some were warnings that a small observation was overgeneralized into a claim that the evidence does not support.

The kidney concern, he said, is the biggest myth. The confusion begins with creatinine, a breakdown product of creatine metabolism. Creatinine appears on standard blood work and is used in estimating kidney function through eGFR. People taking creatine may show elevated creatinine because they have more creatine available to break down, not necessarily because the kidneys are damaged. Doctors sometimes see a higher creatinine value, advise stopping creatine, then see the marker normalize — a pattern Candow described as a false positive “99 out of 100 times.”

Creatinine can also be elevated by a high-meat diet, dehydration, or exercise. His practical advice was simple: tell the doctor if you are taking creatine, because creatinine may be modestly higher. He also said randomized controlled trials over several years have shown no detrimental kidney effects from creatine at recommended dosages in the populations studied. For those with pre-existing medical conditions, he said they should speak to a doctor. DOAC Community Notes stated that creatine is considered safe for most healthy people, but people who are pregnant, breastfeeding, or have kidney disease should speak to a doctor first because creatine can raise blood creatinine and complicate monitoring.

The water-retention myth is more nuanced. Candow did not deny that creatine can cause water retention if too much is taken too quickly. A loading phase of 20 to 30 grams daily for five to seven days can increase water retention acutely, often for several days. But after a maintenance phase of three to five grams daily, he said that water retention goes away in the bloating sense most people worry about. The water that remains is largely inside the muscle.

That intracellular water is part of why creatine may help muscle adapt. Creatine is osmotic: water follows it into muscle. Candow described the muscle as more “volumized,” and said that a swollen muscle can stimulate protein synthesis pathways. In this explanation, the water effect is not just cosmetic or negative; it is one of the mechanisms by which creatine supports lean tissue and training adaptation.

The scale of weight change is also often overstated. Candow cited a six-week creatine study showing an increase in body mass of 0.86 kilograms, most of it lean mass. Lean mass includes water, connective tissue, organs, and skeletal muscle; about half of lean mass is muscle. In another part of the discussion, he said creatine with weight training increases lean mass by about 1.2 kilograms, again noting that only about half is skeletal muscle. The larger effect, in his view, is not huge hypertrophy but better performance and training capacity.

The “only for men” claim, Candow said, is “100% false.” Across the evidence he reviewed, females respond robustly to creatine supplementation, with benefits in strength, endurance, performance, lean mass, and some reduction in fat mass. He said his group has done meta-analyses suggesting creatine reduces fat mass, countering the idea that water retention translates to fat gain. He also emphasized that his lab’s bone work has shown favorable responses in females, especially postmenopausal women.

The hair-loss myth traces, according to Candow, to a decades-old rugby-player study in which 20 to 25 grams per day for seven days increased DHT, a hormone linked to hair follicle miniaturization in genetically susceptible people. But the DHT increase remained within the biological range, and the study did not measure hair thinning or follicle loss. A later test using five grams daily in young males over six to eight weeks of training found no detrimental effect on hair thinning or follicle loss. Candow, bald himself, joked that he was going bald before he started taking creatine.

The cramping myth, he said, is “overplayed.” Because creatine draws water into muscle, he framed it as superhydrating muscle rather than dehydrating it. If dehydration is one contributor to cramps, creatine would not be expected to worsen that mechanism. In hot months, he said, creatine may be “one of your best friends.”

The product market adds a separate problem, and Candow separated two issues: the evidence-based form and the quality-control safeguards. On form, he recommended creatine monohydrate because the safety and efficacy evidence is built on that version. Creatine monohydrate is creatine linked to one water molecule; once consumed, the water molecule dissolves and the creatine is identical to what the liver and brain produce. Newer marketed forms, including hydrochloride, may have evidence behind them, but Candow said they have not been shown to be safer or more effective than monohydrate.

On quality control, his buying checklist was Creapure and third-party testing such as NSF certification. He described third-party testing as a way to obtain a certificate of analysis and check for contaminants such as lead or arsenic. When Steven Bartlett mentioned off-the-shelf testing by James Smith that found many creatine products lacked creatine, Candow said that was why third-party testing matters. If a product does not clearly show third-party testing, he strongly advised against consuming it.

The muscle case for creatine is not that it magically builds large amounts of muscle in isolation. Darren Candow emphasized training capacity: people can train harder, longer, or more frequently, and recover quicker. That increased volume then contributes to adaptation.

In an eight-week training-volume comparison, volume was defined as reps multiplied by weight. Candow explained that when participants took creatine, training volume rose; when they stopped, volume fell back toward placebo levels; when they resumed, it rebounded. He described this as evidence that creatine enhances training capacity. Someone taking creatine might notice more reps, more sets, more load, or better recovery between sessions.

The effect also has implications for detraining and rehabilitation. Elevated creatine in skeletal muscle takes about a month to return to baseline after stopping supplementation. For the brain, evidence is thinner, but Candow said it is speculated to take five weeks to three months for elevated levels to come down. Because muscle stores decline gradually after stopping, he suggested creatine may help people returning from injury by accelerating the rehabilitation program when they resume training.

The muscle-mass effect is real but modest. Creatine plus weight training should produce greater increases than weight training alone across ages, and it may decrease protein breakdown, helping muscle maintain integrity and recover. But Candow repeatedly distinguished muscle performance from dramatic muscle gain. The evidence is more robust for strength, power, endurance, training volume, and functional performance than for large increases in muscle tissue.

Functional ability mattered to him because creatine’s relevance increases with age. An older adult’s sit-to-stand ability translates into getting off the toilet, out of bed, or out of a car. Those are not cosmetic outcomes. They determine independence.

The broader exercise argument was even stronger than the supplement argument. Candow called weight training the “hammer” in the health toolbox and placed it above creatine. If someone could choose only one modality of exercise, he said weight training may be slightly superior to cardio because it provides cardiovascular benefits while also preserving muscle and the skeletal system. Done correctly, weight training can improve mitochondrial health and even VO2 max. But he did not dismiss cardio: everyone should do both.

The common misconception is that muscle building always requires heavy lifting. Lighter weights can produce similar muscle-mass gains if performed with high effort, near fatigue. Heavy lifting remains better if the specific goal is maximal strength. That gives people flexibility: lighter, high-effort sessions on low-energy or sore days; heavier sessions when ready.

For cardio, Candow cited the common recommendation of 150 minutes of moderate physical activity per week, roughly 21 or 22 minutes daily, ideally with higher intensity when possible. For weight training, two or more days per week is enough to matter, and a whole-body routine can work. Monday-Wednesday-Friday whole-body training is fine; body-part splits are optional.

The urgency comes from the muscle-loss curve. Muscle mass peaks in early adulthood, declines gradually from about 40, and falls more substantially after 50. Candow said the average sedentary inactive person loses about 1% of muscle mass per year after 40, while strength declines faster, around 1% to 3% per year. Resistance training can help plateau that decline. Starting at 60, 80, or even 100 can still provide benefits, but starting earlier builds and preserves a higher reserve.

Protein, in this model, is the nutritional partner to exercise. Candow called exercise king and nutrition queen. Protein and creatine together can act as a “force multiplier” for lean tissue mass and performance. He suggested many people today likely get enough total protein, proposing a range of 1.2 to 1.6 grams per kilogram of body weight, with about one gram per pound as a likely maximum for people training intensely five or six days per week. More protein does not all go to muscle; it is also used for hormones, blood cells, and other functions. The better question, he said, is whether people get enough high-quality protein. Vegans and vegetarians can, but may need to eat more to obtain all essential amino acids.

Darren Candow’s bone claims were measured. Creatine is not an osteoporosis cure, and he did not claim it increases bone density. The benefit he described was reduced loss of bone mineral density and some maintenance or improvement of bone structure, particularly around the hip in postmenopausal females — and only when combined with exercise.

The dosing difference is important. For muscle, three to five grams may be enough. For bone, Candow said the lowest dose shown to have bone benefits is eight grams, with studies ranging up to 12 grams daily. In his lab’s work, approximately eight to 12 grams per day with exercise appeared to reduce the rate of bone mineral density loss around the hip in postmenopausal women. Without exercise, he said, no study has shown bone benefits.

Mechanistically, creatine was described as energizing bone-building cells while reducing the activity of osteoclasts, the bone-breakdown cells. Candow compared the effect loosely to bisphosphonates, drugs used to slow bone breakdown in osteoporosis, while making clear that creatine is not a drug. The suggested value is in bone turnover: more support for the building side, less breakdown, and therefore better preservation of structure.

That preservation matters because hip fractures can have severe consequences in older adults. Candow said a fractured hip can lead to long-term care or at least six months of inactivity. Creatine’s bone effect, as he described it, is not dramatic on a scan, but could be meaningful if it helps someone preserve enough structure and function to avoid fracture after a fall.

The menopause discussion extended this logic. Estrogen is involved in creatine metabolism, including enzymes needed to make creatine, and has major effects on brain bioenergetics and muscle metabolism. As women move from premenopause through perimenopause and postmenopause, estrogen declines. Candow argued that creatine may be especially relevant in that transition because of its combined effects on muscle, bone, and cognition.

He also raised a prevention question rather than only an intervention question: what if younger premenopausal females built up tissues earlier, so that later decline starts from a higher baseline? He did not present that as settled; he described it as the direction researchers hope to investigate.

The brain is the most popular and least settled part of the creatine story. Darren Candow repeatedly cautioned that creatine does not “boost” a healthy brain in a simple stimulant-like way. It likely helps bring stressed brain energy back toward normal and may, in some contexts, add a little more.

The brain weighs about two kilograms but uses roughly 20% of daily energy at rest. Because it makes its own creatine, a healthy, well-rested brain may already have enough. The problem is stress. Sleep deprivation, jet lag, exams, night shifts, emergency medicine, military aviation, high-pressure performances, travel across time zones, and cumulative daily stressors can turn a healthy brain into a metabolically stressed brain.

Creatine’s difficulty crossing the blood-brain barrier complicates the dosing. Low daily doses that saturate muscle may not meaningfully affect the brain, at least not quickly. Candow therefore separated the brain evidence into several different cases rather than one generic “cognition” claim.

First, acute sleep deprivation appears to require high acute dosing in the evidence he discussed. A German study gave young participants 30 grams during a 21-hour sleep-deprivation protocol. Candow said that dose increased brain creatine and offset some negative effects. A subsequent lower-dose study using around 0.2 grams per kilogram, roughly 14 grams, did not show the same effect. His working interpretation was that a stressed brain may need much more creatine than muscle does, but that this is not a reason to take 20 or 30 grams every day.

Second, the Stroop-test evidence involved a different protocol: 20 grams per day for seven days. The Stroop test requires a person to name the ink color of color words while ignoring the written word itself. Bartlett struggled quickly when trying it. Candow noted that one study required participants to do the task for 90 straight minutes, an intentionally fatiguing cognitive load. In that study, participants took 20 grams per day in advance, and Candow said it improved their speed and cognition on the task. DOAC Community Notes stated that one study found creatine improved Stroop task accuracy by 4.9% compared with placebo after participants took 20 grams per day for seven days, while noting that it did not improve all cognitive tasks tested.

Third, Alzheimer’s evidence is early and clinically interesting but limited. Candow cited single-arm studies by Matt Taylor and Aaron Smith using 20 grams per day for eight weeks, which increased brain creatine levels and appeared to improve memory and cognition measures. Bartlett added details from a 20-patient study: 20 grams daily for eight weeks increased brain creatine levels by 11% and improved cognitive test scores; it also showed modest muscle gains and a 1.9 kilogram increase in hand grip strength. Candow emphasized the limitation: there was no placebo group, so the findings are encouraging but not definitive.

Fourth, depression and anxiety evidence was presented mainly as adjunctive. Creatine added to SSRIs, cognitive behavioral therapy, or other medically supervised treatments has appeared to improve symptoms. Bartlett cited a trial in women with major depression where adding five grams of creatine to a daily antidepressant doubled remission over eight weeks. Candow confirmed it and attributed the work to Perry Renshaw’s group in Utah. He said he is collaborating on research to test creatine as a standalone treatment versus placebo, but that remains future work rather than an established clinical use.

The proposed mechanisms overlap across these brain-related findings: improved brain bioenergetics, neural transmission or neuromodulation, reduced inflammation, and possibly increased BDNF, a protein involved in brain plasticity. Candow also confirmed Bartlett’s reference to a study of more than 200,000 adults in which those consuming the least dietary creatine had the highest rates of depressive symptoms. He described that as consistent with a broader pattern: people with depression or anxiety, like those with concussion or Alzheimer’s, often show reduced baseline creatine stores.

The cognitive benefit, when it appears, may not be felt subjectively. Bartlett asked whether a person would feel as if they had slept. Candow said they likely would not feel anything. The benefit shows up when performing tasks: memory, basic cognitive work, puzzles, exams, or high-fatigue attention tests.

Sleep sits between performance and brain health. Bartlett cited a study in young athletes who took five grams daily and slept an average of one hour longer on training days. Candow said his group conducted that study in young biological females, where creatine users slept an hour longer than placebo on training days. He called it interesting and in need of replication, including in males. The mechanism is not settled: if creatine improves brain recovery, one might expect less sleep need, but the study showed more sleep. Candow speculated that training at higher capacity may have allowed better homeostasis.

Darren Candow’s safety position was strong but bounded. He said he has published over 120 papers on creatine, conducted at least 30 to 40 studies in his lab, and has not found a category of healthy person who cannot or should not take creatine at recommended dosages. He also described a study from the previous year looking at more than 25,000 cases and said creatine, even over 10 grams a day for many years, had been very safe and effective in that analysis.

That is not the same as a universal medical recommendation. People with pre-existing medical conditions should speak to a doctor. Pregnancy is an area where research is still developing. Candow mentioned Dr. Stacy Ellery’s work in Australia examining human trials in pregnancy, breast milk, and fetal exposure, and said the area is in its infancy; as currently understood, creatine seems relatively safe and well tolerated, but the jury is still out. Separately, DOAC Community Notes advised people who are pregnant, breastfeeding, or have kidney disease to speak to a doctor first.

For children, Candow said the current body of evidence supports safety at recommended dosages in adolescents and teenagers. Reviews suggest creatine can improve balance, agility, and body composition, and children may want at least one gram per day for bone health and muscle development. But he again advised parents to speak to a medical practitioner. For babies and infancy, he said human data remain limited, though Australian work is beginning.

Timing, by contrast, appears flexible. Candow said his group had just had a paper accepted “putting the nail in the coffin” on timing: creatine can be taken at any time of day. Morning, pre-workout, during a workout, after, or before bed are all acceptable. He noted that evening use has not shown detrimental effects in one study, though he said sleep effects have not been fully assessed.

The more important issue is consistency. Creatine is not caffeine. It usually does not produce an immediate, obvious effect. With three to five grams, muscle benefits may take a few weeks to a month to notice. At low doses, brain effects are unlikely unless the person is metabolically stressed. This makes habit design important. Bartlett said he keeps supplements where his routine already goes: desk, green room, coffee machine. Candow said his creatine is on the counter near other supplements, not hidden away.

Food sources can help but are limited. Creatine is found mainly in animal-based flesh: seafood, red meat, and poultry. Herring, salmon, and beef were named as higher-creatine foods. Milk and dairy contain very small amounts; Candow joked that one would need to drink all the milk in a Jersey cow to get enough. Vegans and vegetarians synthesize creatine from amino acids but get no dietary creatine because creatine is only in animal flesh. Candow said they respond “literally the best on the planet” to supplementation.

Gummies and other delivery forms can work if they meet the same quality criteria. Some companies have demonstrated validity and reliability, and gummies can be useful for children, older adults, people with reduced chewing ability or taste sensation, or anyone who benefits from convenience. But the same standard applies: third-party tested, high-quality creatine, and a verified source of creatine in the product.

Darren Candow did not offer a single perfect dose. He said creatine researchers still do not know the best dose for every person or the protocol that checks every box, especially for the brain. But his practical hierarchy was clear enough to use.

For general muscle performance, three to five grams per day is the evidence-based baseline. Three grams can saturate skeletal muscle in about 30 days; five grams is the familiar one-scoop daily dose. A loading phase of roughly 20 grams per day can saturate muscle faster, but Candow treated loading as optional, not necessary.

For older adults focused on muscle, he suggested a little more may be reasonable — about seven to eight grams — because creatine in the lower legs may be more jeopardized with age. For bone, the range rises again: eight to 12 grams per day, with exercise, is where he said benefits have been shown. Without exercise, he said, bone benefits have not been demonstrated.

For a healthy brain, he was explicitly cautious. The brain makes its own creatine, and a healthy, well-rested brain may not need supplementation. For a stressed brain, the research he discussed moves into higher acute protocols: around 20 grams for some cognitive-stress work, 20 to 25 grams as a stressed-state range, and 30 grams in the acute 21-hour sleep-deprivation study. He warned against turning those high-dose acute protocols into a permanent daily habit.

Candow’s own routine sits between the baseline and the experimental high-dose end. He takes at least 10 grams per day as a personal safety net for muscle, bone, and some stress exposure. During acute travel stress, he said he was taking 20 to 25 grams, then planned to return to 10 grams when back in Canada.

The weight-loss claim should be read through that hierarchy too. When Bartlett asked whether creatine has direct weight benefits for someone trying to cut fat, Candow said the effect is indirect. Creatine may help reduce fat by increasing lean mass and improving metabolic health, thereby stimulating energy expenditure or turnover. Animal models suggest some cellular effects on fat, but he did not present creatine as a direct fat-loss supplement. If fat mass goes down, he said, it is likely because lean tissue and metabolic health improve.

Darren Candow resisted making creatine the center of health. He called it one tool in a toolbox, not the hammer. The hammer, for him, is weight training. Aerobic training and sleep come before creatine too. Creatine is more like a multifactorial wrench or screwdriver: useful across muscle, bone, brain, and other systems, but still only one part of a broader plan.

That broader plan is lifestyle: resistance training, cardio, protein, sleep, and consistent habits. Candow’s own routine is three to four days per week of weight training plus 20 to 30 minutes of moderate-intensity cardio or spin. He prefers alternating days: weight training Monday, Wednesday, Friday; cardio Tuesday and Thursday; hiking or other activity on weekends. He tries to eat a balanced diet and described sleep as his biggest failure, adding that he has cut caffeine substantially after noon because he may metabolize it slowly.

His supplement list extends beyond creatine: probiotic with food morning and evening, two forms of magnesium including threonate for cognition and function, 2,000 IU of vitamin D, sufficient protein from powder and food, about four grams of omega-3 fatty acids, occasional iron because he does not eat much red meat, a multivitamin, and interest in NAD as an aging-related area still under debate.

His future research interest is increasingly “from the neck up.” He wants to understand creatine in concussion, head trauma, Alzheimer’s, depression, and related brain conditions. He mentioned rodent evidence suggesting creatine before head trauma can speed concussion recovery, raising the possibility of prophylactic use in sports or occupations with head-impact risk. He did not claim that this is established in humans; he described it as a fascinating direction.

The uncertainty remains large even in the most studied areas. Asked whether he might stop researching creatine, Candow said no: five years earlier he might have said yes, but now there is too much left to do. Body size likely matters because larger people have more muscle storage capacity. Stress level likely matters because the brain’s machinery may not keep up under metabolic strain. General recommendations are useful, but the ideal dose is individual.

Candow’s larger health-span argument is that people should not wait until decline is advanced before acting. Aging, in his definition, is deterioration: lower stress tolerance, more pain, harder muscle retention, less speed, more loss of function. Creatine may be one small support, but he returned to the same larger priorities: lift weights, do cardio, eat enough high-quality protein, sleep, build habits that stick, and preserve the ability to do ordinary activities later in life.